Back to 
UBS Group AG
UBS Group AG
EVGN
8 quarters
Position history for UBS Group AG's holdings in Evogene Ltd.
Yes. Ubs holds 10,790 shares of EVGN (Evogene), worth $4,737, as of its Q2 2026 13F filing. It increased the position by 4,438 shares (+69.9%) from Q1 2026. Ubs has held EVGN since Q3 2024, across 8 quarterly 13F filings.
Current Value
$4,737
Current Shares
10,790
Total Value Change
-$21,668
Total Shares Change
+2,189
Quarter-by-Quarter History
Other major holders of EVGN: Citadel Advisors LLC, Jane Street Group, LLC, HRT Financial LP